<DOC>
	<DOC>NCT03030625</DOC>
	<brief_summary>The aim of this study was to determine the efficacy and safety of the implementation of a program of " image-guided focal Intensification dose to intraprostatic dominant lesion " in men with localized prostate cancer (PCa) of intermediate and high risk (criteria NCCN) eligible to receive radiotherapy in the Department of Radiation Oncology of HUP within the established dose escalation protocol with intensity modulated image-guided radiotherapy (IMRT / IGRT).</brief_summary>
	<brief_title>VMAT for Dominant Intraprostatic Lesion</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Male &gt; 18 years old with histologic diagnostic of prostate adenocarcinoma Clinical stage cT2a‐T3b N0‐1 M0 (AJCC 7 th edition) PSA &lt; 100 ng/ml Gleason score 6‐10 Life expectancy &gt; 5 years Patients who accept the radiotherapy treatment Patients provided written informed consent before participating in the trial Transurethral resection of the prostate or prior prostate surgery Previous pelvic radiotherapy Urethral stenosis with or without prior dilations IPSS&gt;15 Rectal diverticuli or rectal vascular malformations Metastatic disease Severe psychiatric or medical conditions that could hamper both treatment and followup</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Prostate Cancer</keyword>
	<keyword>VMAT</keyword>
	<keyword>Dominant Intraprostatic Lesion</keyword>
	<keyword>Intensity modulated radiotherapy</keyword>
</DOC>